Institute for Cancer Research

 

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded.

The Institute has internationally strong research groups within biochemistry, cell and tumor biology, genetics, radiation biology, immunology and cancer prevention. For more than 30 years there has been a close interaction between researchers at the Institute and cancer surgeons, oncologists and pathologists. This emphasis on translational science has resulted in numerous clinical protocols based on in-house research, and the Institute is a key partner in the Comprehensive Cancer Center, organizationally under the Division of Surgery and Cancer Treatment at Oslo University Hospital.

Gunnar Sæter<br>Scientific director
Gunnar Sæter
Scientific director

Scientific production - Institute for Cancer Research

  Publications Doctoral theses
2014 so far  
2013 201 27
2012  184 18
2011 185 22
2010 200 11
2009 173 21
2008 146 11

Department overview

 

Latest news

Nansen prize for excellent research to Kirsten Sandvig

 
K. Sandvig
K. Sandvig

The Fridtjof Nansen prize for excellent research in science and medicine 2014 is awarded professor Kirsten Sandvig from the Department of Biochemisty at OUS and CCB at UiO for her groundbreaking work within biochemistry and cell biology.
Prizewinner Sandvig receives a medal, a diploma and 150,000 NOK at a ceremony on the 5th of May at the Norwegian Academy of Science and Letters.

 
 

Successful cancer genomics conference at Losby followed up by national media

 
Participants Rolf I. Skotheim and Ragnhild A. Lothe - prominent researchers within the field
Participants Rolf I. Skotheim and Ragnhild A. Lothe - prominent researchers within the field

Oncologists and cancer researchers from all over Norway convened at Losby gods outside Oslo on March 27-28th to participate in the first meeting held in Norway on the subject cancer genomics - entitled "Kreftgenomikk - vår nye hverdag" ("Cancer genomics - our new everyday life"). The meeting was opened by Minister of Health and Care Services Bent Høie. Talks were held by prominent cancer researchers - many of these from the Division of Cancer Medicine, Surgery and Transplantation, OUS.
The conference, which was organized by professors Ragnhild A . Lothe, Dept of Cancer Prevention Institute of Cancer Research, and Per Eystein Lønning, Haukeland University Hospital, through "Norsk kreftsatsing", has attracted attention from the Norwegian media, and several of the participants have been interviewed on national radio.

 
 

Hanne Harbo appointed "Scientist of the Month" by "Helse Sør-Øst" for March 2014

 
Hanne F. Harbo<br>Photo Ram Gupta
Hanne F. Harbo
Photo Ram Gupta

The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by calling special attention to a "Scientist of the Month".

For the month of March 2014, this honour went to Hanne Harbo, head of the "Multiple Sclerosis (MS) research group" at the Department of Neurology at the Division of Surgery and Clinical Neuroscience, Oslo University Hospital.

 
 

Oslo Epigenetics Symposium 9. - 11. April 2014

 

Epigenetics is a rapidly expanding research field that explores heritable alterations in cells and organisms not controlled by their DNA sequence. Epigenetic research is highly relevant to human health as well as agriculture and climate change.

Oslo Epigenetics Symposium 2014 held in Oslo 9.-11. April present cutting-edge epigenetic research from top international researchers. Registration is still open.

The public lecture 9th of April "Epigenetic inheritance- what is the impact ?" is by Dag E. Undlien from OUS and is free upon registration.

 
 

Guest lecturer Wednesday April 2nd

Dr. Paul S. Meltzer

 

The institute seminar on Wednesday April 2nd will was held by the distinguished guest lecturer dr. Paul S. Meltzer, Head of the Molecular Genetics Section and Branch Chief at the Center for Cancer Research, National Cancer Institute, U.S.

Title of his talk: Bringing the New Sequencing Technologies to the Oncology Clinic: Opportunities and Challenges

 
 

Information about EU program supporting career development:

Web TV broadcast of MSCA presentation

 

The institute seminar Wednesday March 26 was held by Per Magnus Kommandantvold and Theodossis A. Theodossiou from The Research Council of Norway, and the subject of their talks was "Presentation of MSCA". This was a continuation of the recent presentation of the EUs new research programme - Horizon 2020.

Marie Sklodowska-Curie Actions (MSCA) is one of the activities in the Excellent Science-pillar of Horizon 2020, and is focused on research training and mobility.

The MSCA presentations are now available on Web TV.